Toru Naganuma

Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry

Davide Capodanno, Tommaso Gori, Holger Nef et al. · EuroIntervention · 2015 · 450 citations

Impact of the Clinical Frailty Scale on Outcomes After Transcatheter Aortic Valve Replacement

Tetsuro Shimura, Masanori Yamamoto, Seiji Kano et al. · Circulation · 2017 · 295 citations · Full text

Treatment and Clinical Outcomes of Transcatheter Heart Valve Thrombosis

Azeem Latib, Toru Naganuma, Mohamed Abdel‐Wahab et al. · Circulation Cardiovascular Interventions · 2015 · 285 citations · Full text

Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development and internal validation of the PSP score

Luis Ortega‐Paz, Davide Capodanno, Tommaso Gori et al. · EuroIntervention · 2017 · 133 citations

ABSORB Biodegradable Stents Versus Second-Generation Metal Stents

Alessio Mattesini, Gioel Gabrio Secco, Gianni Dall’Ara et al. · JACC: Cardiovascular Interventions · 2014 · 126 citations

Tissue Engineering, Engineering, Vascular Surgery +5